18F-rhPSMA-7.3 PET/MRI in Prostate Cancer Active Surveillance: A Pilot Study

Clinical Trials, Metastatic Castration Resistant Prostate Cancer (MCRPC)

— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives

NCT Number: NCT05707182
Phase: EARLY_PHASE1
Trial Summary: The purpose of this study is to investigate the usefulness of PET/MRI with an investigational radioactive drug, 18F-rhPSMA-7.3, and MRI contrast in evaluating patients with prostate cancer eligible fo – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): University of Alabama at Birmingham
Acronym:

Pin It on Pinterest